Target intelligence / Profile preview

Multidrug resistance protein MexY (MexY)

Target
MexY
Molecular classification
Transporter, Resistance-Nodulation-Division (RND) family protein
01

Overview

Multidrug resistance protein MexY is a key component of the MexXY-OprM efflux system in Pseudomonas aeruginosa, a major opportunistic pathogen. As a member of the Resistance-Nodulation-Division (RND) family, MexY serves as the cytoplasmic membrane transporter that recognizes and expels a wide range of antibiotics, including aminoglycosides, macrolides, and fluoroquinolones [1][2]. The mexY gene is part of the mexXY operon, which is frequently overexpressed in multidrug-resistant clinical strains, especially in the context of chronic respiratory infections like cystic fibrosis [2][3]. This efflux activity significantly decreases the intracellular accumulation of drugs, thereby conferring high-level resistance and complicating therapeutic interventions. Because of its central role in antibiotic evasion, MexY is considered a high-priority target for the development of efflux pump inhibitors (EPIs) designed to potentiate the activity of co-administered antibiotics [1][4]. These inhibitors aim to block the pump's mechanism, effectively trapping the antibiotic inside the bacterial cell to reach its lethal concentration. Research into MexY also focuses on its unique ability to transport aminoglycosides, a trait not shared by many other RND pumps in P. aeruginosa [2]. Understanding the structural basis of MexY substrate specificity is crucial for designing next-generation antimicrobials that can bypass this resistance mechanism. Sources: [1] UniProt Consortium. UniProtKB - P52003 (MEXY_PSEAE). https://www.uniprot.org/uniprotkb/P52003/entry [2] Morita Y, Tomida J, Kawamura Y. MexXY multidrug efflux system of Pseudomonas aeruginosa. Front Microbiol. 2012;3:408. https://pubmed.ncbi.nlm.nih.gov/23226144/ [3] Poole K. Efflux-mediated resistance to fluoroquinolones in Gram-negative bacteria. Antimicrob Agents Chemother. 2000;44(9):2233-2241. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC90055/ [4] Lomovskaya O, Watkins WJ. Inhibition of efflux pumps: role in drug discovery. Chem Rev. 2001;101(10):2801-2814. https://pubmed.ncbi.nlm.nih.gov/11749388/

Other names
MexYRND efflux transporter MexYAminoglycoside resistance protein MexYResistance-Nodulation-Division efflux pump subunit MexY
02

Mechanism of action

Efflux pump inhibition to restore antibiotic sensitivity and increase intracellular drug accumulation.

03

Biological functions

Multidrug effluxAntibiotic resistanceXenobiotic transportCation-coupled active transport
04

Disease associations

InfectionCystic fibrosis-associated lung infectionMultidrug-resistant Pseudomonas aeruginosa infectionNosocomial pneumonia
05

Safety considerations

Potential toxicity of efflux pump inhibitors in human cellsOff-target inhibition of essential host transportersCompensatory upregulation of alternative efflux systemsPoor pharmacokinetic properties of current experimental inhibitors
06

Interacting drugs

Amikacin

7 more in the full profile.

07

Biomarkers

mexY mRNA expression levelsmexXY operon upregulationAminoglycoside resistance phenotype

Beyond the preview

Go deeper on Multidrug resistance protein MexY (MexY).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Multidrug resistance protein MexY (MexY).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call